NCT00453206View on ClinicalTrials.gov

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

February 28, 2014

Study Completion Date

August 31, 2014

Conditions
Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
Interventions
PROCEDURE

allogeneic bone marrow transplantation

PROCEDURE

allogeneic hematopoietic stem cell transplantation

PROCEDURE

nonmyeloablative allogeneic hematopoietic stem cell transplantation

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT00453206 - Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases | Biotech Hunter | Biotech Hunter